New research: Anti-ulcer drug shows promise in suppressing coronavirus

Generally, metal compounds are used as anti-microbial agents, but their antiviral activities have rarely been explored, the researchers said.

This 2020 electron microscope image shows SARS-CoV-2 virus particles which causes Covid-19, isolated from a patient in the US, emerging from the surface of cells cultured in a lab. (NIAID-RML via AP)

Researchers from Hong Kong have reported a novel antiviral strategy for treatment of Covid-19. They have found that a class of existing drugs, which are currently used in the treatment of other infectious diseases, can suppress replication of SARS-CoV-2 and relieve Covid-19 symptoms in an animal model.

Their findings are published in Nature Microbiology.

These are metallodrugs, which consist of metal compounds. Generally, metal compounds are used as anti-microbial agents, but their antiviral activities have rarely been explored, the researchers said.

📣 Click to follow Express Explained on Telegram

Their findings now provide a new therapeutic option for treatment of Covid-19. The researchers screened metallodrugs and related compounds including ranitidine bismuthcitrate(RBC), a commonly used anti-ulcer drug which contains the metal bismuth.

Story continues below this ad

They identified RBC as a potent anti SARS-CoV-2 agent. RBC targets a protein called Nsp13, which is essential for SARS-CoV-2 to replicate.

The experiments showed that RBC reduces viral loads by over 1,000-fold in SARS-CoV-2-infected cells.

In a golden Syrian hamster, RBC was found to suppress SARS-CoV-2 replication and reduce viral loads by 100-fold in both the upper and lower respiratory tracts, and to mitigate virus-associated pneumonia.

Source: Hong Kong University

'Remain in US, avoid travel': Microsoft, JP Morgan, Amazon advise visa holders to return before Trump’s $100,000 H-1B fee deadline

‘Stay in US, avoid travel’: Firms advise H-1B visa holders to return before fee deadline

World2 hr ago

Microsoft and JP Morgan have warned their employees on H-1B and H-4 visas to return to the US before September 21 due to President Trump's new visa fee rules. Amazon has also advised against international travel. The policy includes a $100,000 annual surcharge on H-1B visas and has caused market fluctuations. It will be in effect for at least 12 months.

View all shorts

More Explained

Explained ExplainSpeaking: Understanding US Fed’s dual mandate dilemma through 6 quotes from Jerome Powell